250
Participants
Start Date
May 4, 2009
Primary Completion Date
February 1, 2018
Study Completion Date
January 31, 2021
Upstream therapy
Aldosterone receptor antagonists and statins, dietary restrictions, counseling, and cardiac rehabilitation.
Conventional rhythm control
Usual care for atrial fibrillation and heart failure according to the present guidelines
Ziekenhuisgroep Twente, Almelo
Onze Lieve Vrouwe Gasthuis, Amsterdam
Hospital Rijnstate, Arnhem
Ter Gooi Hospital, Blaricum
Amhia Hospital, Breda
Ommelander Hospital Group, Delfzijl
Deventer Hospital, Deventer
Oosterscheldeziekenhuis, Goes
Martini Hospital, Groningen
University Medical Center Groningen, Groningen
Kennemer Gasthuis, Haarlem
Medical University Center Maastricht, Maastricht
University Medical Center Nijmegen, Nijmegen
Viecuri Hospital, Venlo
Ommelander Hospital Group, Winschoten
City Hospital (Sandwell and West Birmingham Hospitals NHS Trust), Birmingham
University Hospitals Birmingham NHS Foundation Trust, Birmingham
Leeds Teaching Hospitals NHS Trust, Leeds
Poole Hospital NHS Foundation Trust, Poole
Good Hope Hospital (Heart of England NHS Foundation Trust), Sutton Coldfield
The Interuniversity Cardiology Institute of the Netherlands
OTHER_GOV
Netherlands Heart Foundation
OTHER
Dutch Network for Cardiovascular Research
UNKNOWN
Trial Coordination Center UMC Groningen
UNKNOWN
Bayer
INDUSTRY
Boehringer Ingelheim
INDUSTRY
Medtronic
INDUSTRY
Biotronik SE & Co. KG
INDUSTRY
Abbott Medical Devices
INDUSTRY
Boston Scientific Corporation
INDUSTRY
AstraZeneca
INDUSTRY
I.C. Van Gelder
OTHER